Crinetics Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 9.09 M | $464.74 M | 44.56% | 11.35% |
| FMR LLC | 02/13/2025 | 8.93 M | $456.49 M | 100.37% | 11.15% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.52 M | $384.25 M | 14.74% | 9.38% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 6.95 M | $355.38 M | 55.85% | 8.68% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 6.14 M | $313.99 M | 4.35% | 7.67% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 5.41 M | $276.84 M | 9.50% | 6.76% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 4.29 M | $219.25 M | 0.00% | 5.35% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 4.08 M | $208.36 M | 250.70% | 5.09% |
| STATE STREET CORP | 02/14/2025 | 2.99 M | $152.92 M | 5.37% | 3.73% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 2.80 M | $142.90 M | 15.06% | 3.49% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 2.79 M | $142.60 M | 21.22% | 3.48% |
| JENNISON ASSOCIATES LLC | 01/24/2025 | 2.71 M | $138.48 M | -3.05% | 3.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.10 M | $107.34 M | 13.57% | 2.62% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 1.91 M | $97.70 M | -24.08% | 2.39% |
| SIREN, L.L.C. | 02/14/2025 | 1.61 M | $82.30 M | 22.91% | 2.01% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 1.59 M | $81.38 M | 14.50% | 1.99% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 1.00 M | $51.28 M | -6.14% | 1.25% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 1.00 M | $51.13 M | -9.09% | 1.25% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 999,000 | $51.08 M | -4.86% | 1.25% |
| NOVO HOLDINGS A/S | 02/14/2025 | 960,215 | $49.10 M | -3.98% | 1.20% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 885,453 | $45.27 M | -6.16% | 1.11% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 851,400 | $43.53 M | 1.97% | 1.06% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 848,050 | $43.36 M | -6.62% | 1.06% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 759,126 | $38.81 M | 15.82% | 0.95% |
| LORD, ABBETT & CO. LLC | 02/14/2025 | 724,625 | $37.05 M | -2.88% | 0.90% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 721,269 | $36.88 M | -8.36% | 0.90% |
| UBS GROUP AG | 02/14/2025 | 707,730 | $36.19 M | 286.98% | 0.88% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 679,123 | $34.72 M | -7.34% | 0.85% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 617,035 | $31.55 M | 17.34% | 0.77% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 609,014 | $31.14 M | -17.15% | 0.76% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 576,068 | $29.45 M | 17.23% | 0.72% |
| FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 559,287 | $28.60 M | 16.01% | 0.70% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 527,792 | $26.99 M | 2.64% | 0.66% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 516,431 | $26.41 M | 20.97% | 0.64% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 502,690 | $25.70 M | -18.51% | 0.63% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 477,298 | $24.40 M | 23.37% | 0.60% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 460,000 | $23.52 M | 15.00% | 0.57% |
| FIERA CAPITAL CORP | 01/29/2025 | 454,982 | $23.26 M | -2.38% | 0.57% |
| FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 453,376 | $23.18 M | 28.30% | 0.57% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 445,946 | $22.80 M | -9.13% | 0.56% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 389,220 | $19.90 M | 0.15% | 0.49% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 355,174 | $18.16 M | 110.79% | 0.44% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 344,765 | $17.63 M | 10.52% | 0.43% |
| 02/28/2025 | 334,783 | $17.12 M | 100.00% | 0.42% | |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 325,276 | $16.63 M | 19.70% | 0.41% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 317,060 | $16.21 M | 48.29% | 0.40% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 300,000 | $15.34 M | 0.00% | 0.37% |
| INVESCO LTD. | 02/13/2025 | 298,254 | $15.25 M | 16.82% | 0.37% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 294,100 | $15.04 M | 1.62% | 0.37% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 281,451 | $14.39 M | -18.03% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Crinetics Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 278 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 9.09 M
FMR LLC: 8.93 M
BlackRock Funding, Inc. /DE: 7.52 M
WELLINGTON MANAGEMENT GROUP LLP: 6.95 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 6.14 M
PRICE T ROWE ASSOCIATES INC /MD/: 5.41 M
124.46% of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 105.87 M shares in the last 24 months. This purchase volume represents approximately $5.35 B in transactions.